Scientists establish link between inflammatory process and progression of Alzheimer's disease
Researchers have shown that a well-known inflammatory process plays an important role in Alzheimer's disease. This process, which results in the mature production of the pro-inflammatory cytokine called interleukin-1 beta and is involved in the body's defense against infection, has also been established as a clinical target for rheumatoid arthritis. The finding points to the possibility that drugs that disrupt IL-1B may also prove beneficial for patients with Alzheimer's.